Saturday, December 28, 2013

Forbes: Revolutionary Hepatitis C Drug Too Expensive? polyDNA Recommends Affordable Gene-Eden-VIR, an HCV Remedy

Rochester, NY (PRWEB) December 27, 2013

polyDNA has learned that Gilead Sciences’ new drug against hepatitis C “is so effective, Wall Street analysts say, that it’s possible public health officials could begin thinking about eradicating the liver-damaging virus (1).” However, the high cost of the drug, which is reported to be $ 1,000 per pill and $ ...

No comments:

Post a Comment